Independent · non-commercial · publishes on a quarterly cycle|Current cycle 2026 Q3
Compound Evidence InstituteEvidence synthesis · established 2023Graded assessments of compounds, trials, methods and supply
Document set current to 30 July 2026
Public comment period · §3

Draft standard CEI-MS-08: Related-substances profiling and… — disposition

The disposition of every submission and the amendments that resulted.

Document identifier
CEI-CP-089/3
Series
Public comment period
Version
1.0
Published
26 Jan 2026
Last reviewed
26 Jan 2026
Next review
26 Jan 2027
Identifier
10.71829/cei.cp.89
Certainty
Not rated
Cycle
2025 Q4
Window
06 Nov 2025 – 01 Jan 2026
Status
Closed
Submissions
9

§3Disposition and amendments

§3.1Disposition table

Table 1. Every submission with its disposition. Each row links to the submission in full.

ReferenceRespondentPoint raisedDisposition
DRAFT-RELATED-SUBS/001Professor Bartolomeu Nkosi-LindegaardNothing prevents a chromatogram being reprocessed until it passesAccepted in part
DRAFT-RELATED-SUBS/002Dr Kamila Glendinning-UcheThe standard assumes a reference standard of known assigned contentAccepted
DRAFT-RELATED-SUBS/003Dr Jolyon Grünbaum-SowandeAcceptance criteria are expressed in terms specific to one instrument familyAccepted in part
DRAFT-RELATED-SUBS/004Dr Xenia Nyquist-ObioraTerms are used in senses that differ from established pharmacopoeial usageAccepted
DRAFT-RELATED-SUBS/005Dr Fenella Steenkamp-FerreiraA field classified as critical is not one a reading turns onAccepted in part
DRAFT-RELATED-SUBS/006Quentin Whitmarsh-ObiA determination does not record the version of the standard it was made underAccepted
DRAFT-RELATED-SUBS/007Dr Theodora TrelawneyThe matrix interferes with the determination and no control is requiredAccepted
DRAFT-RELATED-SUBS/008Dr Zebedee Zaleski-MbekiNothing requires a laboratory to demonstrate ongoing performanceAccepted in part
DRAFT-RELATED-SUBS/009Ms Rhiannon Okoye-VandergraafThe document is unreadable without specialist trainingAccepted in part
9 submissions in total.

§3.2Summary by disposition

Table 2. Counts by disposition, with the meaning of each.

DispositionCountMeaning
Accepted4The submission is accepted and the draft is amended as proposed. The amendment is recorded in the amendment log of the document it changed and is traceable to the numbered submission.
Accepted in part5Part of the submission is accepted and part is not. The secretariat response states which part is which and on what ground the remainder was declined.
Noted, no amendment0The submission raises a point the Institute accepts but that does not require a change to the draft, most often because the draft already states it elsewhere. The location is given in the response.
Not accepted0The submission is not accepted. The secretariat response gives the reason. A submission that is not accepted remains published in full; the Institute does not remove a submission because it disagrees with it.

§3.3Resulting amendments

  1. Nothing prevents a chromatogram being reprocessed until it passes — arising from DRAFT-RELATED-SUBS/001. The standard now requires the processing method and its version to be recorded with every result and the primary data to be retained. A full audit trail is recommended and not required, since it depends on software many laboratories in scope do not run.
  2. The standard assumes a reference standard of known assigned content — arising from DRAFT-RELATED-SUBS/002. The standard now states which determinations remain available without a reference standard of assigned content, requires that such determinations be labelled as relative rather than absolute, and requires the assumption used in place of an assigned content to…
  3. Acceptance criteria are expressed in terms specific to one instrument family — arising from DRAFT-RELATED-SUBS/003. The acceptance criteria are now expressed in instrument-independent quantities, with the conversion from the common manufacturer-specific reporting units given in a note so that a laboratory can check conformance without recalculating by hand.
  4. Terms are used in senses that differ from established pharmacopoeial usage — arising from DRAFT-RELATED-SUBS/004. The three terms now follow established pharmacopoeial usage, the glossary records the definition and its source, and where the Institute uses a term in a narrower sense the departure is stated at first use in the standard.
  5. A field classified as critical is not one a reading turns on — arising from DRAFT-RELATED-SUBS/005. The classification test is now stated in the standard: a field is critical where its absence changes the meaning of a reported figure or prevents attribution to a batch. One field has been reclassified under that test and the reasoning recorded.
  6. A determination does not record the version of the standard it was made under — arising from DRAFT-RELATED-SUBS/006. Every determination reported under this standard now carries the standard identifier and version on its face, and a claim of conformance that does not identify the version is recorded by the Institute as not conformant.
  7. The matrix interferes with the determination and no control is required — arising from DRAFT-RELATED-SUBS/007. An inhibition and enhancement control is now required for every determination under this standard, with stated recovery limits, and a determination reported without it is recorded as not conformant rather than as a low result.
  8. Nothing requires a laboratory to demonstrate ongoing performance — arising from DRAFT-RELATED-SUBS/008. The standard now requires that system suitability results be trended across runs and that a determination report whether the trend was within the laboratory's stated limits, which places the demonstration inside the document the Institute can read.
  9. The document is unreadable without specialist training — arising from DRAFT-RELATED-SUBS/009. Every document now opens with a plain-language summary of not more than 150 words, placed above the technical abstract and carrying the same certainty language, so that the two cannot diverge.

References cited on this page

References are numbered in order of first citation in this document. Each superscript in the text links to its entry below.

  1. International Organization for Standardization. ISO/IEC 17025:2017 General Requirements for the Competence of Testing and Calibration Laboratories. ISO/IEC Standard 2017;3rd edition. identifier not held by the Institute

Identifiers are reproduced only where the Institute holds them. Where a digital object identifier or PubMed identifier is not shown, the Institute has recorded the journal and year and has not constructed an identifier.

Nothing published by the Institute is medical advice, a diagnosis, a prescription, a treatment recommendation or a purchasing recommendation. Compounds supplied for research use are not approved for human or veterinary use in any jurisdiction, and a favourable analytical assessment of a supplier is not a statement that any product is safe or effective. The Institute publishes certainty ratings and never recommendations. No telephone number, messaging handle or ordering channel appears anywhere on this site.